Closure of Trading Window
Filed with BSE · · 1 page · English
Sub: Closure of trading window Unit: Vista Pharmaceuticals Limited (Scrip Code: 524711) We would like to inform you that as per the Company's minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading)Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP/
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Nov 14 2024
- Intimation Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015 - ''Issue Of World Health Organisation (WHO) G.M.P. Certificate.
- Vista Pharmaceuticals Ltd. Press Release Nov 13 2024
- Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vista Pharmaceuticals Ltd. Press Release Nov 07 2024
Later from Vista Pharmaceuticals
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vista Pharmaceuticals Ltd. Press Release Jan 20 2025
- Board Meeting Intimation for Un Audited Financials Results For The Quarter Ended 31.12.2024
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2025
- Results For The Quarter And Nine Months Ended 31.12.2024
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals